Danaher Corporation (LON:0R2B)
London · Delayed Price · Currency is GBP · Price in USD 227.41
+1.41 (0.62%)
Nov 28, 2025, 5:00 PM BST
Danaher Market Cap
Danaher has a market cap or net worth of 121.01 billion as of November 28, 2025. Its market cap has decreased by -10.86% in one year.
Market Cap
121.01B
Enterprise Value
133.58B
Revenue
18.10B
Ranking
n/a
PE Ratio
46.33
Stock Price
227.41
Market Cap Chart
Since December 10, 1969, Danaher's market cap has increased from 207.76M to 121.01B, an increase of 58,145.07%. That is a compound annual growth rate of 12.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 121.01B | -8.63% |
| Dec 31, 2024 | 132.43B | -1.32% |
| Dec 29, 2023 | 134.20B | -16.31% |
| Dec 30, 2022 | 160.36B | -7.64% |
| Dec 31, 2021 | 173.63B | 50.22% |
| Dec 31, 2020 | 115.58B | 38.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 219.39B |
| GSK plc | 72.88B |
| Haleon | 33.03B |
| Smith & Nephew | 10.71B |
| ConvaTec Group | 4.61B |
| Hikma Pharmaceuticals | 3.48B |
| HUTCHMED (China) | 1.87B |
| Genus | 1.68B |